MetaCap

BioLineRx Ltd. ADR Company Profile

NASDAQ: BLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9639-0.0861 (-8.20%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BioLineRx at a glance

BioLineRx Ltd. ADR (NASDAQ: BLRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Hevel Modi'in, Israel. BioLineRx employs about 20 people. At a market capitalization of $4.8 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001498403, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does BioLineRx do?

BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Business description based on the company's public filings.

Company information

Legal name
BioLineRx Ltd. ADR
Ticker
NASDAQ: BLRX
Industry
Biotechnology: Pharmaceutical Preparations
Employees
20
Headquarters
Modi’in Technology Park, Hevel Modi'in, Israel
Phone
972 8 642 9100
SEC CIK
0001498403

Companies similar to BioLineRx

BLRX peer companies
CompanyPrice% ChgMarket capCompare
PULMPulmatrix Inc.1.27-10.56%$4.64Mvs BLRX
SNGXSoligenix Inc.0.2201-8.29%$5.14Mvs BLRX
PCSAProcessa Pharmaceuticals Inc.1.56-7.69%$4.37Mvs BLRX
CANFCan-Fite Biopharma Ltd ADR1.44-2.34%$4.35Mvs BLRX
CNSPCNS Pharmaceuticals Inc.3.56-12.75%$5.25Mvs BLRX
UPCUniverse Pharmaceuticals Inc. Class A1.08-20.59%$5.43Mvs BLRX
TOVXTheriva Biologics Inc.0.12-6.25%$5.51Mvs BLRX
SCNXScienture Holdings Inc.2.28-6.45%$4.07Mvs BLRX

Related